Home / Import refusals / NUV-3855286-8/100002/1

FDA Import Refusal NUV-3855286-8/100002/1 — AbbVie Inc.

AbbVie Inc. — FEI 1411365

The FDA refused shipment NUV-3855286-8/100002/1 from AbbVie Inc. (United States) on November 3, 2025. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 179 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 3, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
58SCP14 ADALIMUMAB
Charges
179

Recent inspections

  • 1306856 (NAI Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1243191 (VAI Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1070526 (NAI Fri Aug 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 934438 (VAI Thu Aug 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 820023 (NAI Fri Mar 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-0768117-3/10002/1A (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-9968726-6/20003/1 (Wed Jan 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 799-9161571-9/10001/1 (Sun Dec 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8712399-1/10001/1 (Fri Dec 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7803787-9/10001/1 (Tue Nov 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources